Findings of a new preclinical study published online in Nature Communications may help address lingering questions relevant to the long-term durability of approved hemophilia A gene therapy. The research was led by Lindsey A. George, director of…
The U.S. Food and Drug Administration (FDA) is holding a public webinar that will speak to the ways in which a strong support network can help mitigate some of the inherent challenges associated with clinical trial participation. Finding…
October 24, 2024 The Bleeding Disorders Association of South Carolina has provided a list of Hurricane Helene Resources and access to their disaster relief program. According to the chapter…
A recent communication has been released regarding the memorial service for the late Neil Frick, a cherished colleague whose passing has deeply affected the National Bleeding Disorders Foundation (NBDF) and the bleeding disorders community.Neil…
On October 11, 2024, Pfizer announced that the U.S. FDA approved HYMPAVZI™ (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and pediatric individuals 12 years of age and older with…
Speaker: Lindsey A. George, MD Are you or a loved one affected by hemophilia A? Curious about cutting-edge treatments that could change lives? Join us for an exciting webinar where Dr. Lindsey A. George will shed…
Speakers:Katherine Bush, LCSW at the Hemophilia Center of Western Pennsylvania Shanna Garcia, Director of Development, Texas Central Bleeding DisordersSupporting Your Teen’s Mental Health: Key Strategies for Parents…
October HANDI Highlights is dedicated to an historically underserved group within the inherited bleeding disorders community - women, girls, and people with the propensity to menstruate (WGPPM). While awareness of these populations has increased in…